Literature DB >> 23109073

Single-use cutting blocks and trials lower costs in primary total knee arthroplasty.

Michael A Mont1, Robert Pivec, Aaron J Johnson, Kimona Issa.   

Abstract

Because total knee arthroplasty is one of the most common orthopaedic procedures, it is important that the medical community continually strive for cost reductions. This prospective controlled trial aimed to determine if cost decreases could be achieved in non-navigated and navigated procedures by replacing traditional saws, cutting blocks, and trials with a specialized single-use system. Costs were lowered by an estimated $140.00-220.00 per surgery as a result of fewer instrument trays being reprocessed, and an estimated $75.00-330.00 per instrument case due to a 10-24-minute time savings during tray rewrapping. This study has positive financial implications for patients, hospitals, institutions, and third-party carriers.

Entities:  

Mesh:

Year:  2012        PMID: 23109073

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  4 in total

1.  Implant Removal Matrix for the upper Extremity Orthopedic Surgeon.

Authors:  Patrick K Cronin; Ian T Watkins; Matthew Riedel; Philip B Kaiser; John Y Kwon
Journal:  Arch Bone Jt Surg       Date:  2020-01

2.  Comparative Cost Analysis of Single-use Sterile versus Reprocessed Distal Radius Volar Plate Sets.

Authors:  Justin A Ly; William L Wang; Frederic E Liss; Asif M Ilyas; Christopher M Jones
Journal:  Arch Bone Jt Surg       Date:  2022-05

3.  Health costs and efficiencies of patient-specific and single-use instrumentation in total knee arthroplasty: a randomised controlled trial.

Authors:  Andre Attard; Gwenllian Fflur Tawy; Michiel Simons; Philip Riches; Philip Rowe; Leela C Biant
Journal:  BMJ Open Qual       Date:  2019-05-29

4.  Implementing a perioperative efficiency initiative for orthopedic surgery instrumentation at an academic center: A comparative before-and-after study.

Authors:  Richard Capra; Stefano A Bini; Dawn E Bowden; Katherine Etter; Matt Callahan; Richard T Smith; Thomas Parker Vail
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.